Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis

被引：0
|
作者：
Reiki Nishimura
Tomofumi Osako
Yasuhiro Okumura
Mitsuhiro Hayashi
Nobuyuki Arima
机构：
[1] Kumamoto City Hospital,Department of Breast and Endocrine Surgery
[2] Kumamoto City Hospital,Department of Clinical Pathology
来源：
Breast Cancer | 2010年 / 17卷
关键词：
Breast cancer; Ki-67; Neoadjuvant chemotherapy; Predictive factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：269 / 275
页数：6
相关论文
共 50 条
  • [21] Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
    Rui Chen
    Yin Ye
    Chengcheng Yang
    Yang Peng
    Beige Zong
    Fanli Qu
    Zhenrong Tang
    Yihua Wang
    Xinliang Su
    Hongyuan Li
    Guanglun Yang
    Shengchun Liu
    Breast Cancer Research and Treatment, 2018, 170 : 35 - 43
  • [22] Prognostic significance of Ki67 during neoadjuvant chemotherapy in primary unresectable ovarian cancer
    Kaya, Ryusuke
    Takanashi, Hiroko
    Nakajima, Akari
    Saito, Ryosuke
    Yamaguchi, Noriko
    Morimoto, Keiji
    Isonishi, Seiji
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (11) : 3979 - 3989
  • [23] Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer
    Yoshioka, Tatsuya
    Hosoda, Mitsuchika
    Yamamoto, Mitsugu
    Taguchi, Kazunori
    Hatanaka, Kanako C.
    Takakuwa, Emi
    Hatanaka, Yutaka
    Matsuno, Yoshihiro
    Yamashita, Hiroko
    BREAST CANCER, 2015, 22 (02) : 185 - 191
  • [24] Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer
    Tatsuya Yoshioka
    Mitsuchika Hosoda
    Mitsugu Yamamoto
    Kazunori Taguchi
    Kanako C. Hatanaka
    Emi Takakuwa
    Yutaka Hatanaka
    Yoshihiro Matsuno
    Hiroko Yamashita
    Breast Cancer, 2015, 22 : 185 - 191
  • [25] Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy
    Montagna, E.
    Bagnardi, V.
    Viale, G.
    Rotmensz, N.
    Sporchia, A.
    Cancello, G.
    Balduzzi, A.
    Galimberti, V.
    Veronesi, P.
    Luini, A.
    Mastropasqua, M. G.
    Casadio, C.
    Sangalli, C.
    Goldhirsch, A.
    Colleoni, M.
    ANNALS OF ONCOLOGY, 2015, 26 (02) : 307 - 313
  • [26] Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancer
    Zhang, Guojing
    Xie, Wanqing
    Liu, Zhaozhe
    Lin, Chao
    Piao, Ying
    Xu, Long
    Guo, Fang
    Xie, Xiaodong
    TUMORI JOURNAL, 2014, 100 (02): : 136 - 142
  • [27] Ki-67, an elusive marker in the prognosis of breast cancer
    Sood, Neelam
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 150 (03) : 214 - 216
  • [28] Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
    von Minckwitz, Gunter
    Schmitt, Wolfgang D.
    Loibl, Sibylle
    Mueller, Berit M.
    Blohmer, Jens U.
    Sinn, Bruno V.
    Eidtmann, Holger
    Eiermann, Wolfgang
    Gerber, Bernd
    Tesch, Hans
    Hilfrich, Joern
    Huober, Jens
    Fehm, Tanja
    Barinoff, Jana
    Ruediger, Thomas
    Erbstoesser, Erhard
    Fasching, Peter A.
    Karn, Thomas
    Mueller, Volkmar
    Jackisch, Christian
    Denkert, Carsten
    CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4521 - 4531
  • [29] Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy
    Kim, Ji-Yeon
    Oh, Jung Min
    Lee, Se Kyung
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Park, Yeon Hee
    Ahn, Jin Seok
    Kim, Kyunga
    Im, Young-Hyuck
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] The role of Ki-67 in breast cancer
    Mannell, A.
    SOUTH AFRICAN JOURNAL OF SURGERY, 2016, 54 (02) : 10 - 13
12345